ST
LUMO

Spot Trading’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Spot Trading’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$100K Buy
+1,089
New +$83.5K ﹤0.01% 2542
2017
Q2 		– Sell
-656
Closed -$142K – 3508
2017
Q1 		$142K Buy
+656
New +$93.7K ﹤0.01% 2102
2016
Q3 		– Sell
-5,722
Closed -$580K – 3615
2016
Q2 		$580K Buy
5,722
+4,855
+560% +$602K 0.01% 1513
2016
Q1 		$142K Sell
867
-866
-50% -$176K ﹤0.01% 2398
2015
Q4 		$568K Buy
1,733
+266
+18% +$86.6K 0.01% 1834
2015
Q3 		$473K Sell
1,467
-2,333
-61% -$1.02M ﹤0.01% 2092
2015
Q2 		$1.51M Buy
3,800
+3,267
+613% +$1.39M 0.01% 1332
2015
Q1 		$263K Sell
533
-3,378
-86% -$1.31M ﹤0.01% 2570
2014
Q4 		$1.4M Sell
3,911
-389
-9% -$116K 0.01% 1655
2014
Q3 		$829K Buy
4,300
+2,744
+176% +$603K ﹤0.01% 2208
2014
Q2 		$372K Sell
1,556
-588
-27% -$120K ﹤0.01% 2911
2014
Q1 		$548K Buy
+2,144
New +$655K ﹤0.01% 2465
2013
Q4 		– Sell
-3,844
Closed -$650K – 4377
2013
Q3 		$650K Hold
3,844
– – ﹤0.01% 2243
2013
Q2 		$682K Buy
+3,844
New +$544K ﹤0.01% 2202

Other funds holding LUMO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CCI
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return

Spot Trading's LUMO Position: Q3 2017 in Review

Spot Trading opened a new position in Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2017: 1,496 shares worth $137K. The stake represents ﹤0.01% of the portfolio and ranks #2427 among its holdings. This is a return to the name: Spot Trading previously reported a position in LUMO as recently as Q1 2016.

Spot Trading first reported a position in LUMO in Q2 2013 and has held it in 11 quarters since. The position peaked at $4.05M in Q2 2014. 126 funds tracked by Wall St. Rank hold LUMO as of Q3 2017.

  • Spot Trading held 1,496 shares of Lumos Pharma, Inc. Common Stock worth $137K as of Q3 2017.
  • Lumos Pharma, Inc. Common Stock was a new Spot Trading position in Q3 2017.
  • Lumos Pharma, Inc. Common Stock made up ﹤0.01% of Spot Trading's portfolio in Q3 2017, its #2427 holding.
  • Spot Trading first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and has held it in 11 quarters since.
  • Spot Trading's Lumos Pharma, Inc. Common Stock position peaked at $4.05M in Q2 2014.
  • 126 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.